Average Co-Inventor Count = 3.33
ph-index = 65
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cardiothoracic Systems, Inc. (29 from 101 patents)
2. Target Therapeutics, Inc. (28 from 211 patents)
3. Concentric Medical, Inc. (20 from 37 patents)
4. University of California (14 from 15,475 patents)
5. Microvention, Inc. (12 from 269 patents)
6. Other (3 from 832,843 patents)
7. USA As Represented by Secretary of the Navy (2 from 16,080 patents)
8. University of Virginia Patent Foundation (2 from 998 patents)
9. Maquet Cardiovascular LLC (2 from 133 patents)
10. Scimed Life Systems, Inc. (1 from 1,831 patents)
11. Conceptus, Inc. (1 from 58 patents)
12. Biomerix Corporation (1 from 7 patents)
13. Reduction Technologies, Inc. (1 from 2 patents)
14. Maguet Cardiovascular LLC (1 from 1 patent)
15. Erik T. Engelson (0 patent)
111 patents:
1. 12383277 - Embolic containment
2. 11712355 - Implant retention, detachment, and delivery system
3. 11484323 - Embolic containment
4. 11389168 - Temporary aortic occlusion device
5. 11389169 - Temporary aortic occlusion device
6. 11045203 - Occlusive device
7. 10980545 - Devices for vascular occlusion
8. 10898203 - Embolic containment
9. 10617544 - Implant retention, detachment, and delivery system
10. 10555738 - Embolic containment
11. 10342546 - Occlusive device
12. 10076347 - Systems, methods and devices for removing obstructions from a blood vessel
13. 9833252 - Multi-component obstruction removal system and method
14. 9636125 - Systems, methods and devices for removing obstructions from a blood vessel
15. 8771294 - Aneurysm treatment devices and methods